Cyclin E-induced S phase without activation of the pRb/E2F pathway

Genes and Development

Volumn 11, Issue 11, 1997, Pages 1479-1492

  Lukas, Jiri ^a   Herzinger, Thomas ^b   Hansen, Klaus ^a   Moroni, Maria Cristina ^c   Resnitzky, Dalia ^d   Helin, Kristian ^c   Reed, Steven I ^b   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cyclin D1; Cyclin E; E2F; p16; pRb phosphorylation; S phase

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; HUMAN; HUMAN CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0031008465     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.11.1479     Document Type: Article

References (67)

1. Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8: 805-814.
2. Beijersbergen, R.L. and R. Bernards. 1996. Cell cycle regulation by theretinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287: 103-120.
3. 1 cyclin complexes. Genes & Dev. 9: 1340-1353.
4. Botz, J., K. Zerfass-Thome, D. Spitkovski, H. Delius, B. Vogt, M. Eilers, A. Hatzigeorgiou, and P. Jansen-Dürr. 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16: 3401-3409.
5. Boyle, W.J., P. Van der Geer, and T. Hunter 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201: 110-149.
6. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995a. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
7. 1 cyclin-dependent kinase activity. Genes & Dev. 9: 2873-2887.
8. Dirick, L., T. Bohm, and K. Nasmyth. 1995. Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. EMBO J. 14: 4803-4813.
9. Dou, Q.P., A.B. Pardee, and K. Keyomarsi. 1996. Cyclin E - A better prognostic marker for breast cancer than cyclin D? Nature Med. 2: 254.
10. 1 to S trasition in Drosophila: Cyclin E is a limiting downstream target of E2F. Genes &. Dev. 9: 1456-1468.
11. Duronio, R.J., P.H. O'Farrell, J.E. Xie, A. Brook, and N. Dyson. 1995. The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes & Dev 9: 1445-1455.
12. Duronio, R.J., A. Brook, N. Dyson, and P.H. O'Farrell. 1996. E2F-induced S phase requires cyclin E. Genes & Dev. 10: 2505-2513.
13. Fagan, R., K.J. Flint, and N. Jones. 1994. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78: 799-811.
14. Geng, Y., E. Ng Eaton, M. Picón, J.M. Roberts, A.S. Lundberg, A. Gifford, C. Sardet, and R.A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogens 12: 1173-1180.
15. Hall, M. and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-108.
16. Hamel, P.A., R.M. Gill, R.A. Phillips, and B.L. Gallie. 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7: 693-701.
17. Harper, J.W. and S.J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6: 56-64. tran
18. Helin, K. and E. Harlow. 1993. The retinoblastoma protein as a transcriptional represser. Trends Cell Biol. 3: 43-46.
19. Herrera, R.E., V.P. Sah, B.O. Williams, T.P. Mäkelä, R.A. Weinberg, and T. Jacks. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16: 2402-2407.
20. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.I. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006.
21. Hirai, H. and C.J. Sherr. 1996. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell. Biol. 16: 6457-6467.
22. 1 exit. Genes & Dev. 10: 851-861.
23. Ikeda, M.-A., L. Jakoi, and J.R. Nevins. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. 93: 3215-3220.
24. Johnson, L.F. 1992. G1 events and the regulation of genes for S-phase enzymes. Curr. Opin. Cell Biol. 4: 149-154.
25. Knoblich, J.A., K. Sauer, L. Jones, H. Richardson, R. Saint, and C.F. Lehner. 1994. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for arrest of cell proliferation. Cell 77: 107-120.
26. Knudsen, E.S. and J.Y.J. Wang. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271: 8313-8320.
27. Koh, J., G.H. Enders, B.D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510.
28. Lam, E.W.-F. and R.J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12: 2705-2713.
29. LaThangue, N.B. 1994. DRTF1/E2F: An expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19: 108-114.
30. Lukas, J., H. Müller, J. Bartkova, D. Spitkovsky, A.A. Kjerulff, P. Jansen-Dürr, M. Strauss, and J. Bartek. 1994a. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125: 625-638.
31. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994b. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9: 707-718.
32. Lukas, J., J. Bartkova, M. Rohde, M. Strauss, and J. Bartek. 1995a. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15: 2600-2611.
33. Lukas, J., D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995b. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503-506.
34. INK4-mediated growth suppression. Mol. Cell. Biol. 16: 1047-1057.
35. Mayol, X., J. Garriga, and X. Grana. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p 130. Oncogene 11: 801-808.
36. Mann, D.J. and N.C. Jones. 1996. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol. 6: 474-483.
37. Means, A.L., J.E. Slansky, S.L. McMahon, M.W. Knuth, and P.J. Farnham. 1992. The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12: 1054-1063.
38. Medema, R.H., R.E. Herrera, F. Lam, and R.A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. 92: 6289-6293.
39. Moberg, K., M.A. Starz, and J.A. Lees. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16: 1436-1449.
40. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
41. Nevins, J.R. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncogenesis. Science 258: 424-429.
42. Ohtani, K., J. DeGregori, and J.R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. 92: 12146-12150.
43. Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15: 2612-2624.
44. Pagano, M., S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating amounts of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
45. Ink4/MTS1 tumour suppressor gene product. EMBO J. 14: 503-511.
46. Peters, G. 1994. Cell cycle: Stifled by inhibitions. Nature 371: 204-205.
47. Pines, J. 1995. Cyclins and cyclin-dependent kinases: A biochemical view. Biochem. J. 308: 697-711.
48. Reed, S.I. 1996. Cyclin E: In mid-cycle. Biochim. Biophys. Acta 1287: 151-153.
49. Resnitzky, D. and S.I. Reed. 1995. Different roles for cyclins D1 and E in regulation of the Gl-to-S transition. Mol. Cell. Biol. 15: 3463-3469.
50. Resnitzky, D., M. Gossen, H. Bujard, and S.I. Reed. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with inducible system. Mol. Cell. Biol. 14: 1669-1679.
51. Resnitzky, D., L. Hengst, and S.I. Reed. 1995. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol. Cell. Biol. 15: 4347-4352.
52. Roussel, M.F., A.M. Theodoras, M. Pagano, and C.J. Sherr. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. 92: 6837-6841.
53. Rutter, G.A., M.R.H. White, and J.M. Tavare. 1995. Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curt. Biol. 5: 890-899.
54. Schreiber, E., P. Matthias, M.M. Müller, and W. Schaffner. 1989. Rapid detection of octomer binding proteins with "miniextracts," prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
55. Schwob, E., T. Böhm, M.D. Mendenhall, and K. Nasmyth. 1994. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Cell 79: 233-244.
56. Serrano, M., G.J. Hannon, and D. Beach. 1993. A regulatory motif in cell-cycle control causing specific inhibition of cyclin D/cdk4. Nature 366: 704-707.
57. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell 73: 1059-1065.
58. 1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
59. Slansky, J.E. and P.J. Farnham. 1996. Introduction to the E2F family: Protein structure and gene regulation. Curr. Top. Microbiol Immunol. 208: 1-30.
60. Slansky, J.E., Y. Li, W.G. Kaelin, and P.J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13: 1610-1618.
61. Tam, S.W., A.M. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: Association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene 9: 2663-2674.
62. van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
63. Wang, J.Y.J., E.S. Knudsen, and P.J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64: 25-85.
64. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
65. Wimmel, A., F.C. Lucibello, A. Sewing, S. Adolph, and R. Müller. 1994. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9: 995-997.
66. Wu, C.-L., M. Classon, N. Dyson, and E. Harlow. 1996. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol Cell. Biol. 16: 3698-3706.
67. Zhu, L., L. Zhu, E. Xie, and L.S. Chang. 1995. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol Cell. Biol. 15: 3552-3562.